P M Marcus

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Adolescent reproductive events and subsequent breast cancer risk
    P M Marcus
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892 7354, USA
    Am J Public Health 89:1244-7. 1999
  2. ncbi request reprint NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population
    P M Marcus
    Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892 7354, USA
    Pharmacogenetics 10:115-22. 2000
  3. ncbi request reprint Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up
    P M Marcus
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7354, USA
    J Natl Cancer Inst 92:1308-16. 2000
  4. ncbi request reprint Lung cancer screening: an update
    P M Marcus
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892 7354, USA
    J Clin Oncol 19:83S-86S. 2001
  5. ncbi request reprint Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis
    Pamela M Marcus
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20895 7354, USA
    J Natl Cancer Inst 98:748-56. 2006

Collaborators

Detail Information

Publications5

  1. pmc Adolescent reproductive events and subsequent breast cancer risk
    P M Marcus
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892 7354, USA
    Am J Public Health 89:1244-7. 1999
    ..This study investigated the relationship between reproductive events during adolescence and subsequent breast cancer risk...
  2. ncbi request reprint NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population
    P M Marcus
    Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892 7354, USA
    Pharmacogenetics 10:115-22. 2000
    ..5, CI 1.2-1.8; more recent NAT2 genotyping methods: four studies, OR 1.4, CI 1.1-1.7). Our results suggest that in most populations studied to date, NAT2 slow acetylation status is associated with a modest increase in bladder cancer risk...
  3. ncbi request reprint Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up
    P M Marcus
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7354, USA
    J Natl Cancer Inst 92:1308-16. 2000
    ..No lung cancer mortality benefit was evident at the end of the study. We have extended follow-up through 1996...
  4. ncbi request reprint Lung cancer screening: an update
    P M Marcus
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892 7354, USA
    J Clin Oncol 19:83S-86S. 2001
    ..The Lung Screening Study, an ongoing randomized controlled trial of lung cancer screening with spiral CT, also is described...
  5. ncbi request reprint Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis
    Pamela M Marcus
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20895 7354, USA
    J Natl Cancer Inst 98:748-56. 2006
    ..Because that excess could instead have resulted from short follow-up time, we investigated this possibility by conducting long-term lung cancer incidence follow-up...